Skip to main navigation Skip to search Skip to main content

Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate

  • Shan Mei
  • , Zhangling Fan
  • , Xiaoman Liu
  • , Fei Zhao
  • , Yu Huang
  • , Liang Wei
  • , Yamei Hu
  • , Yu Xie
  • , Liming Wang
  • , Bin Ai
  • , Chen Liang
  • , Fengwen Xu
  • , Fei Guo
  • Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College
  • Beijing Hospital
  • Lady Davis Institute-Jewish General Hospital

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number911164
JournalFrontiers in Immunology
Volume13
DOIs
StatePublished - Jul 22 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology

Keywords

  • COVID-19
  • SARS-CoV-2
  • spike protein
  • vaccine
  • vaccinia virus

Fingerprint

Dive into the research topics of 'Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate'. Together they form a unique fingerprint.

Cite this